ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 175 filers reported holding ANTARES PHARMA INC in Q4 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $399,000 | -80.3% | 97,509 | -82.8% | 0.00% | – |
| Q4 2021 | $2,022,000 | +235.9% | 566,664 | +242.5% | 0.00% | – |
| Q3 2021 | $602,000 | +527.1% | 165,469 | +661.4% | 0.00% | – |
| Q2 2021 | $96,000 | -87.6% | 21,731 | -88.4% | 0.00% | – |
| Q1 2021 | $772,000 | +207.6% | 187,937 | +199.0% | 0.00% | – |
| Q4 2020 | $251,000 | +9.1% | 62,859 | -26.2% | 0.00% | – |
| Q3 2020 | $230,000 | -16.4% | 85,220 | -15.0% | 0.00% | – |
| Q2 2020 | $275,000 | +83.3% | 100,214 | +57.8% | 0.00% | – |
| Q1 2020 | $150,000 | -83.3% | 63,507 | -66.7% | 0.00% | – |
| Q4 2019 | $897,000 | +167.8% | 190,986 | +90.7% | 0.00% | – |
| Q3 2019 | $335,000 | -18.1% | 100,156 | -19.4% | 0.00% | – |
| Q2 2019 | $409,000 | +25.8% | 124,271 | +16.0% | 0.00% | – |
| Q1 2019 | $325,000 | +261.1% | 107,134 | +223.0% | 0.00% | – |
| Q4 2018 | $90,000 | -69.9% | 33,164 | -62.7% | 0.00% | – |
| Q3 2018 | $299,000 | +273.8% | 88,938 | +190.9% | 0.00% | – |
| Q2 2018 | $80,000 | -26.6% | 30,572 | -38.8% | 0.00% | – |
| Q1 2018 | $109,000 | +17.2% | 49,975 | +6.9% | 0.00% | – |
| Q4 2017 | $93,000 | -79.0% | 46,751 | -65.7% | 0.00% | – |
| Q3 2017 | $442,000 | +351.0% | 136,338 | +344.2% | 0.00% | – |
| Q2 2017 | $98,000 | +19.5% | 30,694 | +7.1% | 0.00% | – |
| Q1 2017 | $82,000 | +256.5% | 28,664 | +192.5% | 0.00% | – |
| Q4 2016 | $23,000 | +21.1% | 9,800 | -45.9% | 0.00% | – |
| Q2 2016 | $19,000 | +1800.0% | 18,125 | +2140.4% | 0.00% | – |
| Q3 2015 | $1,000 | -83.3% | 809 | -72.8% | 0.00% | – |
| Q2 2015 | $6,000 | -91.3% | 2,971 | -91.3% | 0.00% | – |
| Q1 2015 | $69,000 | +430.8% | 34,309 | +416.0% | 0.00% | – |
| Q4 2014 | $13,000 | +225.0% | 6,649 | +64.5% | 0.00% | – |
| Q3 2014 | $4,000 | 0.0% | 4,041 | +94.1% | 0.00% | – |
| Q2 2014 | $4,000 | -71.4% | 2,082 | -54.8% | 0.00% | – |
| Q1 2014 | $14,000 | -44.0% | 4,609 | -26.7% | 0.00% | – |
| Q4 2013 | $25,000 | +47.1% | 6,286 | +48.8% | 0.00% | – |
| Q3 2013 | $17,000 | -29.2% | 4,225 | -27.5% | 0.00% | – |
| Q2 2013 | $24,000 | – | 5,831 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 500,000 | $2,180,000 | 4.34% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,535,727 | $11,056,000 | 3.87% |
| Sargent Investment Group, LLC | 3,596,250 | $15,680,000 | 3.72% |
| Rubric Capital Management LP | 9,500,000 | $41,420,000 | 2.61% |
| PERKINS CAPITAL MANAGEMENT INC | 541,783 | $2,362,000 | 1.34% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,900,000 | $8,284,000 | 1.14% |
| Venator Capital Management Ltd. | 709,700 | $3,094,000 | 1.05% |
| LEVEL FOUR FINANCIAL, LLC | 120,000 | $523,000 | 0.22% |
| OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $875,000 | 0.19% |
| Brown Advisory Securities, LLC | 275,000 | $1,199,000 | 0.19% |